Гормоны жировой ткани и их роль в формировании гормонального статуса и патогенезе метаболических нарушений у женщин
https://doi.org/10.18705/1607-419X-2015-21-4-356-370
Аннотация
Об авторе
Ю. В. КовалеваРоссия
кандидат медицинских наук, доцент кафедры акушерства и гинекологии имени С.Н. Давыдова,
ул. Кирочная, д. 41, Санкт-Петербург, 193015
Список литературы
1. Blüher M, Mantzoros CS. From leptin to other adipokinesin health and disease: facts and expectations at the beginning of the 21st century. Metabolism. 2015;64(1):131–45. doi: 10.1016/j.metabol.2014.10.016
2. Mitchell M, Armstrong DT, Robker RT, Norman RJ. Adipokines: implications for female fertility and obesity. Reproduction. 2005;130(5):583–597.
3. Schäffler A, Müller-Ladner U, Schölmerich J, Büchler C. Role of adipose tissue as an inflammatory organ in human diseases. Endocr Rev. 2006;27(5):449–67.
4. Smitka K, Marešová D. Adipose tissue as an endocrine organ: an update on pro-inflammatory and anti-inflammatory microenvironment. Prague Med Rep. 2015;116(2):87–111. doi: 10.14712/23362936.2015.49.
5. Galic S, Oakhill JS, Steinberg GR. Adipose tissue as an endocrine organ. Mol Cell Endocrinol. 2010;316(2):129–139.
6. Hausman GJ, Barb CR, Lents CA. Leptin and reproductive function. Biochimie. 2012;94(10):2075–2081.
7. McMillen JC, Edwards LJ, Duffield J, Muhlhausler BS. Regulation of leptin synthesis and secretion before birth: implications for the early programming of adult obesity. Reproduction. 2006;131(3):415–427.
8. Shimizu H, Oh IS, Okada S, Mori M. Leptin resistance and obesity. Endocr J. 2007;54(1):17–26.
9. Antuna-Puente B, Feve B, Fellahi S, Bastard JP. Adipokines: the missing link between insulin resistance and obesity. Diabetes Metab. 2008;34(1):2–11.
10. Blüher M. Adipose tissue dysfunction in obesity. Exp Clin Endocrinol Diabetes. 2009;117(6):241–250.
11. Ghantous CM, Azrak Z, Hanache S, Abou-Kheir W, Zeidan A. Differential role of leptin and adiponectin in cardiovascular system. Int J Endocrinol. 2015;2015:534320. doi: 10.1155/2015/534320
12. Hausman GJ, Barb CR. Adipose tissue and the reproductive axis: biological aspects. Endocr Dev. 2010;19:31–44.
13. Raucci R, Rusolo F, Sharma A, Colonna G, Castello G, Costantini S. Functional and structural features of adipokine family. Cytokine. 2013;61(1):1–14. doi: 10.1016.
14. Guerre-Millo M. Adiponectin: an update. Diabetes Metab. 2008;34(1):12–8.
15. Matsuzawa Y. Adiponectin: a key player in obesity related disorders. Curr Pharm Des. 2010;16(17):1896–1901.
16. Groth SW. Adiponectin and polycystic ovary syndrome. Biol Res Nurs. 2010;12(1):62–72. doi: 10.1177/1099800410371824
17. Aleidi S, Issa A, Bustanji H, Khalil M, Bustanji Y. Adiponectin serum levels correlate with insulin resistance in type 2 diabetic patients. Saudi Pharm J. 2015;23(3):250–256. doi: 10.1016/j.jsps.2014.11.011
18. Tilg H, Moschen AR. Role of adiponectin and PBEF/visfatin as regulators of inflammation: involvement in obesity-associated diseases. Clin Sci (Lond). 2008;114(4):275–288. doi: 10.1042/CS20070196
19. Spranger J, Kroke A, Möhlig M, Bergmann MM, Ristow M, Boeing H et al. Adiponectin and protection against type 2 diabetes mellitus. Lancet. 2003;361(9353):226–228.
20. Park SE, Park CY, Sweeney G. Biomarkers of insulin sensitivity and insulin resistance: Past, present and future. Crit Rev Clin Lab Sci. 2015;4:1–11.
21. Okamoto Y, Arita Y, Nishida M, Muraguchi M, Ouchi N, Takahashi M et al. An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls. Horm Metab Res. 2000;32(2):47–50. doi: 10.1055/s‑2007–978586.
22. Orio F Jr, Palomba S, Cascella T, Milan G, Mioni R, Pagano C et al. Adiponectin levels in women with PCOS. J Clin Endocrinol Metab. 2003;88(6):2619–2623.
23. Toulis KA, Goulis DG, Farmakiotis D, Georgopoulos NA, Katsikis I, Tarlatzis BC et al. Adiponectin levels in women with polycystic ovary syndrome: a systematic review and a meta-analysis. Hum Reprod Update. 2009;15(3):297–307. doi: 10.1093/humupd/dmp006
24. Yokota T, Oritani K., TakahashiI, Ishikawa J, MatsuyamaA, Ouchi N et al. Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood. 2000;96(5):1723–1732.
25. Ouchi N, Kihara S, Arita Y, Okamoto Y, Maeda K, Kuriyama H et al. Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-κВ signaling through a cAMPdependent pathway. Circulation. 2000;102(11):1296–1301.
26. Wolf AM, Wolf D, Rumpold H, Enrich B, Tilg H. Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RAin human leukocytes. Biochem Biophys Res Commun. 2004;323(2):630–635.
27. Riestra P, Garcia-Anguita A, Ortega L, Garcés C. Relationship of adiponectin with sex hormone levels in adolescents. Horm Res Paediatr. 2013;79(2):83–87.
28. Fischer-Posovszky P, Wabitsch M, Hochberg Z. Endocrinology of adipose tissue — an update. Horm Metab Res. 2007;39(5):314–321.
29. Waki H, Tontonoz P. Endocrine functions of adipose tissue. Annu Rev Pathol. 2007;2:31–56.
30. Fonseca-Alaniz MH, Takada J, Alonso-Vale MI, Lima FB. Adipose tissue as an endocrine organ: from theory to practice. J Pediatr (Rio J). 2007;83(Suppl 5):S192–203.
31. Maury E, Brichard SM. Adipokine dysregulation, adipose tissue inflammation and metabolic syndrome. Mol Cell Endocrinol. 2010;314(1):1–16. doi: 10.1016/j.mce.2009.07.031
32. Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw. 2006;17 (1):4–12.
33. Heilbronn LK, Campbell LV. Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity. Curr Pharm Des. 2008;14(12):1225–1230.
34. Thomas S, Suresh S, Sudheesh M, Vijayakumar T. Association of insulin resistance with adipocytokine levels in patients with metabolic syndrome. ndian J Clin Biochem. 2015;30(2):155–160. doi: 10.1007/s12291–014–0423–7
35. Клебанова Е.М., Балаболкин М.И. Гормоны жировой ткани и их роль в патогенезе сахарного диабета 2‑го типа. Лечащий врач. 2010;11:27–33. [Klebanova EM, Balabolkin MI.
36. Hormones of adipose tissue and their role in the pathogenesis of type2 diabetes mellitus. Lechaschiy vrach = Physician. 2010;11:27–33. In Russian].
37. Coppack SW Pro-inflammatory cytokines and adipose tissue. Proc Nutr Soc. 2001;60 (3):349–356.
38. Axelsson J, Heimbürger O, Lindholm B, Stenvinkel P. Adipose tissue and its relation to inflammation: the role of adipokines. J Ren Nutr. 2005;15(1):131–136.
39. Calabrò P, Limongelli G, Pacileo G, Di Salvo G, Golino P, Calabrò R. The role of adiposity as a determinant of an inflammatory milieu. J Cardiovasc Med (Hagerstown). 2008;9(5):450–60.
40. Grant RW, Stephens JM. Fat in flames: Influence of cytokines and pattern recognition receptors on adipocyte lipolysis. Am J Physiol Endocrinol Metab. 2015: ajpendo.00053.2015. doi: 10.1152/ajpendo.00053.2015
41. Bastard JP, Jardel C. Elevated levels of interleukin 6 are reduced in serum and subcutaneous adipose tissue of obese women after weight loss. J Clin Endocrinol Metab. 2000;85 (9):3338–3342.
42. Tsai S, Clemente-Casares X, Revelo XS, Winer S, Winer DA. Are obesity-related insulin resistance and type 2 diabetes autoimmune diseases? Diabetes. 2015;64(6):1886–1897. doi: 10.2337/db14–1488
43. Havel PJ. Update on adipocyte hormones. Regulation of energy balance and carbohydrate/lipid metabolism. Diabetes. 2004;53(Suppl 1):S143–151.
44. Cianflone K, Xia Z, Chen LY. Critical review of acylationstimulating protein physiology in humans and rodens. Biochem Biophys Acta. 2003;1609(2):127–143.
45. Tanaka T, Nabescima Y. Nampt/PBEF/Visfatin: a new player in beta cell physiology and in metabolic diseases? Cell Metab. 2007;6(5):341–343.
46. Krzysik-Walker SM, Ocón-Grove OM, Maddineni SR, Hendricks GL. 3rd, Ramachandran R is visfatin an adipokine or myokine? Evidence for greater visfatin expression in skeletal muscle than visceral fat in chickens. Endocrinology. 2008;149 (4):1543–1550.
47. Sethi JK, Vidal-Puig A. Visfatin: the missing link between intra-abdominal obesity and diabetes? Trends Mol Med. 2005;11(8):344–347.
48. Araki S, Dobashi K, Kubo K, Kawagoe R, Yamamoto Y, Kawada Y et al. Plasma visfatin concentration as a surrogate marker for visceral fat accumulation in obese children. Obesity. 2008;16 (2):384–348. doi: 10.1038/oby.2007.54
49. Algasham AA, Barakat YA. Serum visfatin and its relation to insulin resistance and inflammation in type 2 diabetic patients with and without macroangiopathy. Saudi Med J. 2008;29(2):185–192.
50. Moschen AR, Kaser A, Enrich B, Mosheimer B, Theurl M, Niederegger H et al. Visfatin, an adipocytokine with proinflammatory and imminomodulating properties. J Immunol. 2007;178(3):1748–1758.
51. Hida K, Wada J, Eguchi J, Zhang H, Baba M, Seida A et al. Visceral adipose tissue-derived serine protease inhibitor: a unique insulin-sensitizing adipocytokine in obesity. Proc. Natl.
52. Acad. Sci. USA. 2005;102(30):10610–10615. doi: 10.1073/ pnas.0504703102
53. Blüher M. Vaspinin obesity and diabetes: pathophysiological and clinical significance. Endocrine. 2012;41(2):176–182. doi: 10.1007/s12020–011–9572–0
54. Youn BS, Klöting N, Kratzsch J, Lee N, Park JW, Song ES et al. Serum vaspin concentrations in human obesity and type 2 diabetes. Diabetes. 2008;57(2):372–377.
55. Körner A, Neef M, Friebe D, Erbs S, Kratzsch J, Dittrich K et al. Vaspin is related to gender, puberty and deteriorating insulin sensivity in children. Int J Obes. 2011;35(4):578–586. doi: 10.1038/ijo.2010.196
56. Klöting N, Berndt J, Kralisch S, Kovacs P, Fasshauer M, Schön MR et al. Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes. Biochem Biophys Res Commun. 2006;339(1):430–436.
57. Li Q, Chen R, Moriya J, Yamakawa J, Sumino H, Kanda T et al. A novel adipocytokine, visceral adipose tissue-derived serine protease inhibitor (vaspin), and obesity. J Int Med Res. 2008;36 (4):625–629.
58. Boucher J, Masri B, Daviaud D, Gesta S, Guigné C, Mazzucotelli A et al. Apelin, a newly identified adipokine upregulated by insulin and obesity. Endocrinology. 2005;146 (4):1764–1771.
59. Tasci I, Dogru T, Naharci I, Erdem G, Yilmaz MI, Sonmez A et al. Plasma apelin is lower in patients with elevated LDL-cholesterol. Exp Clin Endocrinol Diabetes. 2007;115 (7):428–432.
60. Kidoya H, Ueno M, Yamada Y, Mochizuki N, Nakata M, Yano T et al. Spatial and temporal role of the apelin/APJsastem in the calibre size regulation of blood vessels during angiogenesis. EMBO J. 2008;27(3):522–534. doi: 10.1038/sj.emboj.7601982
61. García-Díaz D, Campión J, Milagro FI, Martínez JA. Adiposity dependent apelin gene expression: relationships with oxidative and inflammation markers. Mol Cell Biochem. 2007;305 (1–2):87–94.
62. de Souza Batista CM, Yang RZ, Lee MJ, Glynn NM, Yu DZ, Pray J et al. Omentin plasma level and gene expression and are decreased in obesity. Diabetes. 2007;56(6):1655–1661.
63. Yang RZ, Lee MJ, Hu H, Pray J, Wu HB, Hansen BC et al. Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action. Am J Physiol Endocrinol Metab. 2006;290(6):E1253–1261.
64. Wurm S, Neumeier M, Weigert J, Schäffler A, Buechler C. Plasma levels of leptin, omentin, collagenous repeatcontaining sequence of 26‑kDa protein (COPS‑26) and adiponectin before and after oral glucose uptake in slim adults. Cardiovasc Diabetol. 2007;6:7. doi: 10.1186/1475–2840–6-7
65. Tan YL, Zheng XL, Tang CK. The protective functions of omentin in cardiovascular diseases. Clin Chim Acta. 2015; pii: S0009–8981(15)00282‑X. doi: 10.1016/j.cca.2015.05.019
66. Fietta P, Delsante G. Focus on adipokines. Theor Biol Forum. 2013;106(1–2):103–29.
67. Matsuzawa Y. The role of fat topology in the risk of disease. Int J Obes (Lond). 2008;32(Suppl 7):S83–92.
68. Klöting N, Blüher M. Adipocyte dysfunction, inflammation and metabolic syndrome. Rev Endocr Metab Disord. 2014;15 (4):277–287. doi: 10.1007/s11154–014–9301–0.
Рецензия
Для цитирования:
Ковалева Ю.В. Гормоны жировой ткани и их роль в формировании гормонального статуса и патогенезе метаболических нарушений у женщин. Артериальная гипертензия. 2015;21(4):356-370. https://doi.org/10.18705/1607-419X-2015-21-4-356-370
For citation:
Kovalyova Y.V. Adipose tissue hormones and their role for female fertility and metabolic disorders. "Arterial’naya Gipertenziya" ("Arterial Hypertension"). 2015;21(4):356-370. (In Russ.) https://doi.org/10.18705/1607-419X-2015-21-4-356-370